M. Cimitan

[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients

M. Cimitan, Roberto Bortolus, Sandro Morassut et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2006 · 312 citations

Medicine, Nuclear Medicine, Radiology +14

Detection and Restaging of Residual and/or Recurrent Nasopharyngeal Carcinoma after Chemotherapy and Radiation Therapy: Comparison of MR Imaging and FDG PET/CT

Maurizio Comoretto, Luca Balestreri, Eugenio Borsatti et al. · Radiology · 2008 · 132 citations

Medicine, Oncology, Radiology +17

Gleason Score at Diagnosis Predicts the Rate of Detection of ¹⁸F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients

M. Cimitan, Laura Evangelista, Marina Hodolič et al. · Journal of Nuclear Medicine · 2014 · 77 citations · Full text

Medicine, Oncology, Urology +17

Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role

M. Cimitan, Angela Buonadonna, Renato Cannizzaro et al. · Annals of Oncology · 2003 · 76 citations · Full text

Medicine, Endocrinology, Oncology +16

Comparison between conventional imaging (abdominal–pelvic computed tomography and bone scan) and [¹⁸F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis

Laura Evangelista, M. Cimitan, Fabio Zattoni et al. · Scandinavian Journal of Urology · 2015 · 58 citations · Full text

Medicine, Nuclear Medicine, Oncology +17